|
Volumn 35, Issue 6, 2003, Pages 2273-2274
|
Liver transplantation across ABO blood groups in children
a,b a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CYCLOSPORIN;
DACLIZUMAB;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RITUXIMAB;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ACUTE GRAFT REJECTION;
ADOLESCENT;
ADULT;
BLOOD ANALYSIS;
BLOOD CHEMISTRY;
BLOOD GROUP A;
BLOOD GROUP ABO SYSTEM;
BLOOD GROUP B;
BLOOD GROUP O;
CAUSE OF DEATH;
CENTRAL NERVOUS SYSTEM DISEASE;
CHILD;
CHRONIC GRAFT REJECTION;
CONFERENCE PAPER;
EMERGENCY TREATMENT;
FOLLOW UP;
FUNCTION TEST;
GRAFT SURVIVAL;
HEART FAILURE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RECIPIENT;
SEPSIS;
SURGICAL MORTALITY;
SURGICAL PATIENT;
TREATMENT OUTCOME;
|
EID: 0141727446
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2003.08.002 Document Type: Conference Paper |
Times cited : (8)
|
References (6)
|